To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1361010
Sale price1.055,10 €
|
Levodopa Related Compound A (50 mg) (3-(2,4,5-Trihydroxyphenyl)-L-alanine |
R09510 | 27244-64-0 | 1.055,10 € | |
|
USP-1362114
Sale price1.107,68 €
|
Levofloxacin Related Compound A (25 mg) ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
R122P0 | 117707-40-1 | 1.107,68 € | |
|
USP-1362125
Sale price979,16 €
|
Levofloxacin Related Compound B (35 mg) ((S)-9,10,difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
R19330 | 100986-89-8 | 979,16 € | |
|
USP-1362136
Sale price979,16 €
|
Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylates) |
R043U0 | 177472-30-9 | 979,16 € | |
|
USP-1362158
Sale price1.018,88 €
|
Levofloxacin Related Compound E (25 mg) ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride) |
R19320 | 1346603-62-0 | 1.018,88 € | |
|
USP-1362169
Sale price1.059,78 €
|
Levofloxacin Related Compound F (25 mg) ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
R089T0 | 117620-85-6 | 1.059,78 € | |
|
USP-1362359
Sale price445,18 €
|
Levomethorphan Solution (3 x 1.2 mL) (0.1 mg/mL 3-methoxy-17-methylmorphinan in methanol) |
R105E0 | 125-70-2 (Levomethorphan) | 445,18 € | |
|
USP-1362624
Sale price1.092,49 €
|
Levonorgestrel-5(10)-ene Isomer (25 mg) |
F25660 | 19914-67-1 | 1.092,49 € | |
|
USP-1362657
Sale price1.279,45 €
|
Levonorgestrel System Suitability Mixture A (15 mg) |
F25840 | N/A | 1.279,45 € | |
|
USP-1362668
Sale price1.080,81 €
|
Levonorgestrel System Suitability Mixture B (15 mg) |
F25850 | NA | 1.080,81 € | |
|
USP-1365043
Sale price1.199,99 €
|
Levothyroxine Peak Identification Mixture (3 x 5 mL) (1 mg/mL) (COLD SHIPMENT REQUIRED) |
F114N0 | N/A | 1.199,99 € | |
|
USP-1366080
Sale price949,94 €
|
Lidocaine Related Compound H (50 mg) (2-Chloro-N-(2,6-dimethylphenyl)acetamide) |
R156H0 | 1131-01-7 | 949,94 € | |
